Schizophrenia News
-
Some Risperdal, Risperidone Tablets Recalled
Drugmaker Johnson & Johnson has issued a recall for lots of the antipsychotic medication Risperdal and its generic equivalent risperidone because of a bad odor reported in some of the tablets. Read Summary > -
Mental Health is Top Health Issue for Young People: Study
Researchers have found that mental health problems are the leading cause of disability among children, teens, and young adults worldwide. Read Summary > -
Study Finds How the Brain IDs Important Info, Distraction
Problems with neurons in the front of the brain may help explain why people with ADHD and schizophrenia have trouble with distraction, a new study suggests. Read Summary > -
New Schizophrenia Drug May Be Most Promising in Years: Expert
A leading psychiatry researcher has called drugmaker Roche's experimental schizophrenia medication RG1678 for treating listlessness and apathy in schizophrenics "the most exciting development [in the treatment of schizophrenia] in a long time." Read Summary > -
New Blood Test May Detect Schizophrenia
A new blood test called the VeriPsych has been designed to look for biomarkers of schizophrenia in a person's blood. Read Summary > -
Children of Mentally Ill Parents Have Higher Murder Risk: Study
Children who have a severely mentally ill parent are almost nine times more likely to be victims of homicide than children who have healthy parents, Dutch researchers have found. Read Summary > -
Research Could Lead to New Schizophrenia Therapies
Scientists say their finding could lead to the development of drugs that could help prevent the psychotic symptoms often seen in people with schizophrenia. Read Summary > -
Schizophrenia Boosts Risk of Osteoporosis
Scientists in Finland have discovered that women who have schizophrenia and men with affective psychosis have lower levels of bone density and vitamin D than the general population. Read Summary >
